This article is more than 5 years old. Information may no longer be current.
Interventions in Ocular Surgery: Reducing Ocular Infection and Inflammation
Sponsorship Statement:
This continuing education activity is jointly sponsored by 
Target Audience: The intended learners for this activity are ophthalmologists and other healthcare professionals involved in the treatment of patients with ophthalmic disorders.
Learning Objectives: At the conclusion of this activity participants should be able to:
- Analyze recent epidemiologic studies of changing susceptibility among pathogens encountered in routine ocular care and describe new anti-infective strategies for treatment.
- Analyze recommendations from the American Society of Cataract and Refractive Surgery and the European Society of Cataract and Refractive Surgery regarding the perioperative use of antibiotic prophylaxis for the prevention of endophthalmitis.
- Discuss the rationale for perioperative use of antibiotics and anti-inflammatories to treat the ocular surface and decrease the risk of postsurgical infection and inflammation to improve patient outcomes.
Course Chair:
Richard L. Lindstrom, MD
Chief Medical Editor
Ocular Surgery News®
Editorial Board Member
Journal of Refractive Surgery and Ophthalmic Surgery Lasers & Imaging®
Adjunct Professor Emeritus
University of Minnesota
Department of Ophthalmology
Founder and Attending Surgeon
Minnesota Eye Consultants, PA
Minneapolis, Minnesota
Faculty:
David R. Hardten, MD
Section Editor, Cornea/External Disease
Ocular Surgery News®
Associate Editor
Journal of Refractive Surgery®
Adjunct Associate Professor of Ophthalmology
University of Minnesota
Partner
Minnesota Eye Consultants
Minneapolis, Minnesota
Edward E. Manche, MD
Editorial Board Member
Journal of Refractive Surgery®
Professor of Ophthalmology
Director of Cornea and Refractive Surgery
Stanford University School of Medicine
Stanford, California
Jay S. Pepose, MD, PhD
Editorial Board Member
Journal of Refractive Surgery®
Director
Pepose Vision Institute
Professor of Clinical Ophthalmology
Washington University School of Medicine
St. Louis, Missouri
External Reviewer:
William C. Lloyd III, MD, FACS (An Employee of Vindico Medical Education)
Accreditation:
This educational activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Ocular Surgery News® and Vindico Medical Education. Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Vindico Medical Education designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, August 25, 2011 to August 24, 2012.
How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the Pretest questions, watch and listen to the presentations, complete the Posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 out of 4 of the Posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the Posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)TM certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Planning Committee and Faculty members report the following relationship(s):
Richard L. Lindstrom, MD
Consultant: Acufocus, Inc., Advanced Medical Optics, Advanced Refractive Technologies, Alcon Laboratories, Inc., Bausch + Lomb, Inc., Bio Syntrx, Bradley Scott, Inc, Calhoun Vision, Inc, Clarity Ophthalmics, Clear Sight, CoDa Therapeutics, EBV Partners, EGG Basket Ventures, Encore, Evision, Eyemaginations, Inc., Foresight Venture Fund #3, Glaukos Corporation, High Performance Optics, Improve Your Vision, I-Therapeutix, Lensar, LenSx, Lifeguard Health, Minnesota Eye Consultants, P.A., NuLens, Ocular Surgery News/Slack, Ocular Optics, Omega Eye Health, Omeros Corporation, Pixel Optics, Quest, Refractec, RXVP, Sight Path, Surgijet/Visijet, 3D Vision Systems, TLC Vision, Tearlabs, Inc., Tracey Technologies, Transcend Medical, Inc., True Vision, Versant, Vision Solutions Technologies
Investor: Acufocus, Inc, Advanced Medical Optics, Bausch + Lomb, Inc., Bio Syntrx, Bradley Scott, Inc., Calhoun Vision, Inc, Clarity Ophthalmics, Clear Sight, CoDa Therapeutics, Confluence Acquisition Partners I, Inc., EBV Partners, EGG Basket Ventures, Encore, Evision, Eyemaginations, Inc., Foresight Venture Fund #3, Fziomed, Glaukos Corporation, HEAVEN Fund, Healthcare Transaction Services, High Performance Optics, Improve Your Vision, I-Therapeutix, Lensar, LenSx, Lifeguard Health, Minnesota Eye Consultants, P.A., NuLens, Ocular Optics, Omega Eye Health, Pixel Optics, Quest, Refractec, Revision Options, RXVP, Schroder Life Science Venture Fund, SightPath, Surgijet/Visijet, 3D Vision Systems, TLC Vision, Tearlabs, Inc., Tracey Technologies, Transcend Medical, Inc, True Vision, Viradax, Vision Solutions Technologies
Royalty: Acufocus, Inc., Bausch + Lomb, Inc., Quest
David R. Hardten, MD
Consultant: Abbott Medical Optics, Inc., Allergan, Inc., ESI, TLCV
Speakers Bureau: Abbott Medical Optics, Inc., Allergan, Inc., ESI, Inspire, ISTA Pharmaceuticals, Inc., Oculus, TLCV, Carl Zeiss Meditec
Research Grant Recipient: Alcon Laboratories, Inc., Allergan, Inc., Inspire, ISTA Pharmaceuticals, Inc., Peschke, Topcon
Edward E. Manche, MD
No relevant financial relationships to disclose.
Jay S. Pepose, MD, PhD
Consulting Fees: Abbott Medical Optics, Inc., Bausch + Lomb
Fees for Non-CME Services: Inspire Pharmaceuticals, TearScience
Ownership Interest: Acufocus, Inc., Visiometrics
External Reviewer reports the following relationship(s):
William C. Lloyd III, MD, FACS (An Employee of Vindico Medical Education)
No relevant financial relationships to disclose.
Ocular Surgery News® and Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-848-1000; Fax: 856-848-6091. Printed in the USA. Copyright © 2011 SLACK Incorporated®. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education and Ocular Surgery News® continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education and Ocular Surgery News®. Neither Vindico Medical Education, Ocular Surgery News®, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.